This pharma stock surged 10X, crashed 60%, and rose to an all-time high again. Can it sustain the momentum?
Retail investors took notice. During the period, the number of public shareholders grew fivefold to 236,000. At the same time, domestic institutions sharply cut their stake, from 31.6% to just 3.6%. But like many fast rallies, this one didn’t last long. As …